The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

The Oncology Institute, Inc.NASDAQ: TOI

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables rises 19.7% from a year ago

Net receivables stood at $59.45M at the end of Q1 FY2026, up 19.7% from a year earlier and up 0.2% from the prior quarter. Over 3 fiscal years it compounded at +13.6% a year.

Context

  • Net receivables amounted to 35.3% of total assets at the end of Q1 FY2026, up 5.1 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +19.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$59.45M+0.2% QoQ
Last fiscal yearDec 2025
$59.32M+21.9% YoY
Year agoMar 2025
$49.67M+19.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.7%——
1 year+21.9%——
3-year CAGR+13.6%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
59.32M USD
Year-over-year change
+21.9%
4-year CAGR
+29.3%

Net Receivables vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +19.7% is the 5th highest of 10, against a peer median of +10.2%.
  • Net receivables amounts to 35.3% of total assets for TOI, versus a peer median of 16.4%.
TOI Competitors
Net Receivables for TOI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AUNAAuna S.A.Mar 2026PEN 1.12B PEN+10.2%+22.5%14.6%
AGLAgilon Health, Inc.Mar 2026$899.75M USD-27.4%+11.0%59.8%
CCRNCross Country Healthcare, Inc.Mar 2026$184.05M USD-21.7%-35.6%40.8%
AUTLAutolus Therapeutics plcMar 2026$86.26M USD+502.5%+37.8%16.4%
TOIThe Oncology Institute, Inc.Mar 2026$59.45M USD+19.7%+13.6%35.3%
KIDSOrthoPediatrics Corp.Mar 2026$54.43M USD+23.7%+29.5%10.8%
EOLSEvolus, Inc.Mar 2026$52.22M USD+10.0%+34.6%23.7%
TMCITreace Medical Concepts, Inc.Mar 2026$30.36M USD-2.4%+13.0%16.5%
SNDASonida Senior Living, Inc.Mar 2026$26M USD+57.9%+44.9%1.0%
CBLLCeriBell, Inc.Mar 2026$15.71M USD+39.1%+41.7%8.8%
Peer median (excluding TOI) —+10.2%+29.5%16.4%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents114.3M14.01M33.49M49.67M33.57M
Short-term Investments059.8M49.37M00
Net Receivables21.24M40.43M42.91M48.68M59.32M
Inventory6.44M9.26M13.68M10.04M16.88M
Other Current Assets875K004.03M2.99M
Total Current Assets154.06M130.42M143.49M112.42M112.75M
Property, Plant & Equipment (Net)4.19M33.04M40.05M37.67M33.06M
Goodwill26.63M21.42M7.23M7.23M7.23M
Intangible Assets18.25M17.96M17.9M14.81M11.02M
Long-term Investments(371K)58.35M000
Tax Assets371K0000
Other Non-current Assets320K477K561K589K606K
Total Non-current Assets49.38M131.25M65.75M60.3M51.91M
Total Assets203.44M261.67M209.24M172.72M164.66M
Account Payables15.56M9.37M14.43M24.32M43.17M
Short-term Debt183K0000
Tax Payables132K255K000
Deferred Revenue592K1.14M545K4.7M2.28M
Other Current Liabilities10.14M9.35M11.33M10.35M13.15M
Total Current Liabilities29.8M29.72M34.79M52.22M70.96M
Long-term Debt080.62M86.83M93.13M77.4M
Deferred Tax Liabilities371K108K32K32K0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities69.11M5.98M4.08M527K12.88M
Total Non-current Liabilities69.48M108.77M117.43M116.91M109.41M
Total Liabilities99.28M138.49M152.22M169.13M180.38M
Common Stock7K7K8K8K10K
Retained Earnings(63.23M)(63.08M)(146.15M)(210.81M)(271.42M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity104.16M123.18M57.03M3.59M(15.72M)
Total Debt183K108.18M119.68M123.15M103.69M
Net Debt(114.12M)94.17M86.19M73.48M70.12M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.